Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse

Por Reid, Richard T, Lloyd, G Kenneth, Rao, Tadimeti S
Publicado em 1999

Discovery and Development of the Anticancer Agent Salinosporamide A (NPI-0052)

Por Fenical, William, Jensen, Paul R., Palladino, Michael A., Lam, Kin S., Lloyd, G. Kenneth, Potts, Barbara C.
Publicado em 2008

Pharmacodynamic and Efficacy Studies of the Novel Proteasome Inhibitor NPI-0052 (marizomib) in a Human Plasmacytoma Xenograft Murine Model

Por Singh, Ajita V., Palladino, Michael A., Lloyd, G. Kenneth, Potts, Barbara, Chauhan, Dharminder, Anderson, Kenneth C.
Publicado no Br J Haematol (2010)

Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation

Por BERTELSEN, LOTTE B., SHEN, YUAN YUAN, NIELSEN, THOMAS, STØDKILDE-JØRGENSEN, HANS, LLOYD, G. KENNETH, SIEMANN, DIETMAR W., HORSMAN, MICHAEL R.
Publicado em 2011

Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier

Por Di, Kaijun, Lloyd, G. Kenneth, Abraham, Vivek, MacLaren, Ann, Burrows, Francis J., Desjardins, Annick, Trikha, Mohit, Bota, Daniela A.
Publicado no Neuro Oncol (2016)

Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs

Por Obaidat, Amanda, Weiss, Jeffrey, Wahlgren, Brett, Manam, Rama R., Macherla, Venkat R., McArthur, Katherine, Chao, Ta-Hsiang, Palladino, Michael A., Lloyd, G. Kenneth, Potts, Barbara C., Enna, Salvatore J., Neuteboom, Saskia T. C., Hagenbuch, Bruno
Publicado em 2011